These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 22007736

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
    Chandler WM, Rowe LR, Florell SR, Jahromi MS, Schiffman JD, South ST.
    Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
    [Abstract] [Full Text] [Related]

  • 7. Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization.
    Hossain D, Qian J, Adupe J, Drewnowska K, Bostwick DG.
    Melanoma Res; 2011 Oct; 21(5):426-30. PubMed ID: 21900793
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, Piris A, Mihm MC.
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [Abstract] [Full Text] [Related]

  • 11. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
    Gammon B, Gerami P.
    Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
    [Abstract] [Full Text] [Related]

  • 12. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
    Vergier B, Prochazkova-Carlotti M, de la Fouchardière A, Cerroni L, Massi D, De Giorgi V, Bailly C, Wesselmann U, Karlseladze A, Avril MF, Jouary T, Merlio JP.
    Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fluorescence in situ hybridization (FISH) analysis of melanocytic nevi and melanomas: sensitivity, specificity, and lack of association with sentinel node status.
    Fang Y, Dusza S, Jhanwar S, Busam KJ.
    Int J Surg Pathol; 2012 Oct; 20(5):434-40. PubMed ID: 22561674
    [Abstract] [Full Text] [Related]

  • 17. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.
    Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M.
    Arch Dermatol; 2010 Mar; 146(3):273-8. PubMed ID: 20231497
    [Abstract] [Full Text] [Related]

  • 18. FISH analysis for diagnostic evaluation of challenging melanocytic lesions.
    Zimmermann AK, Hirschmann A, Pfeiffer D, Paredes BE, Diebold J.
    Histol Histopathol; 2010 Sep; 25(9):1139-47. PubMed ID: 20607656
    [Abstract] [Full Text] [Related]

  • 19. What's new in prognostication of melanoma in the dermatopathology laboratory?
    Bangash HK, Romegialli A, Dadras SS.
    Clin Dermatol; 2013 Sep; 31(3):317-23. PubMed ID: 23608451
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.